Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma

Clinical trial NCT01339663 · COMPLETED

Trial details

NCT number: NCT01339663
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IV Melanoma

Start date: 2012-03-01
Primary completion: 2012-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.